CAD 28.73
(-2.28%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -580.17 Million | 896.88 Million | 134.68 Million | 698.67 Million | -270.09 Million | -397.33 Million |
Net Income | 181.08 Million | 226.58 Million | 57.06 Million | 114.08 Million | 172.71 Million | 224.64 Million |
Depreciation & Amortization | 59.97 Million | 52.48 Million | 61.51 Million | 65.64 Million | 46.59 Million | 42.02 Million |
Deferred income taxes | -18.63 Million | -6.49 Million | -22.05 Million | -17.88 Million | 14.17 Million | 9.1 Million |
Stock-based compensation | 10.88 Million | 2.2 Million | 32.38 Million | -6.97 Million | 18.7 Million | -6.98 Million |
Change in working capital | -845.4 Million | 652.97 Million | -71.3 Million | 18.62 Million | -479.7 Million | -619.67 Million |
Other non-cash items | -22.24 Million | -30.86 Million | -103.32 Million | 401.89 Million | -68.26 Million | -85.53 Million |
Investing Cash Flow | 665.22 Million | -759.03 Million | -29.31 Million | -599.87 Million | 347.76 Million | 448.29 Million |
Investments in PPE | -38.69 Million | -63.04 Million | -40.8 Million | -41.2 Million | -68.61 Million | -160.97 Million |
Acquisitions | - | - | - | - | - | 233 Thousand |
Investment purchases | -3.57 Billion | -4.38 Billion | -3.47 Billion | -3.73 Billion | -3.68 Billion | -5.12 Billion |
Sales/Maturities of investments | 3.72 Billion | 4.61 Billion | 3.46 Billion | 3.4 Billion | 3.94 Billion | 5.18 Billion |
Other Investing Activities | 560.39 Million | -921.37 Million | 24.58 Million | -225.9 Million | 156.7 Million | 548.33 Million |
Financing Cash Flow | -97.08 Million | -140.7 Million | -102.08 Million | -1.85 Billion | -2.45 Billion | -49.6 Million |
Debt repayment | -16.58 Million | -379.14 Million | -19.72 Million | -18.55 Million | -43.06 Million | -162.8 Million |
Dividends payments | -83.07 Million | -92.71 Million | -81.02 Million | -106.29 Million | -102.43 Million | -88.72 Million |
Common Stock Repurchased | 878 Thousand | -17.21 Million | -125 Million | - | - | -100 Million |
Common Stock Issuance | 664 Thousand | 1.91 Million | 48 Thousand | 1.59 Million | 11 Thousand | 139.12 Million |
Other Financing Activities | 1.03 Million | 346.46 Million | 123.61 Million | -1.73 Billion | -2.35 Billion | -878.82 Million |
Accounts receivables | 83.53 Million | -70.87 Million | 5.13 Million | 34.64 Million | -18.12 Million | -9.04 Million |
Accounts payables | - | 22.3 Million | -108.94 Million | -13.46 Million | 29.38 Million | 45.17 Million |
Inventory | - | - | 1.31 Billion | 636.71 Million | 2.99 Billion | -112.9 Million |
Other working capital | -845.4 Million | 701.53 Million | -1.27 Billion | -639.26 Million | -3.48 Billion | -542.89 Million |
Cash at beginning of period | 79.7 Million | 69 Million | 69.66 Million | 90.65 Million | 116.49 Million | 111.97 Million |
Cash at end of period | 69.43 Million | 79.7 Million | 69 Million | 69.66 Million | 90.65 Million | 116.49 Million |
Capital Expenditure | -38.69 Million | -63.04 Million | -40.8 Million | -41.2 Million | -68.61 Million | -160.97 Million |
Effect of forex changes on cash | 1.77 Million | 13.55 Million | -3.94 Million | 3.45 Million | -1.07 Million | 3.15 Million |
Net cash flow / Change in cash | -10.26 Million | 10.7 Million | -659 Thousand | -20.99 Million | -25.83 Million | 4.51 Million |
Free Cash Flow | -618.87 Million | 833.83 Million | 93.87 Million | 657.47 Million | -338.71 Million | -558.3 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 34.1 Million | -117.54 Million | 37.28 Million | 30.62 Million | 181.08 Million | 49.26 Million |
Depreciation & Amortization | 14.14 Million | 15.88 Million | 16.09 Million | 16.7 Million | 59.97 Million | 14.41 Million |
Deferred income taxes | -1.93 Million | -52.52 Million | -14.48 Million | 408 Thousand | -18.63 Million | -2.16 Million |
Stock-based compensation | 100 Thousand | 300 Thousand | 300 Thousand | 9.48 Million | 10.88 Million | -400 Thousand |
Change in working capital | -119.35 Million | 1.08 Billion | -890.07 Million | -691.42 Million | -845.4 Million | 976.36 Million |
Other non-cash items | -31.5 Million | 180.85 Million | 87.87 Million | 137.2 Million | -22.24 Million | -159.36 Million |
Investing Cash Flow | 93.47 Million | -485.07 Million | 1.62 Billion | 510.97 Million | 665.22 Million | -848.88 Million |
Investments in PPE | -10.13 Million | -9.46 Million | -7.66 Million | -11.38 Million | -38.69 Million | -8.52 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -888.01 Million | -395.32 Million | -906.88 Million | -989.64 Million | -3.57 Billion | -699.2 Million |
Sales/Maturities of investments | 682.56 Million | 382.49 Million | 1.55 Billion | 981.92 Million | 3.72 Billion | 621.09 Million |
Other Investing Activities | 103.6 Million | -472.13 Million | 987.87 Million | 530.07 Million | 560.39 Million | -762.25 Million |
Financing Cash Flow | -31.76 Million | -655.38 Million | -848.58 Million | -25.51 Million | -97.08 Million | -25.07 Million |
Debt repayment | -8.33 Million | -167.83 Million | -137.4 Million | -4.11 Million | -16.58 Million | -4.09 Million |
Dividends payments | -22.69 Million | -19.51 Million | -22.8 Million | -19.6 Million | -83.07 Million | -22.39 Million |
Common Stock Repurchased | 16 Thousand | -4000.00 | -12 Thousand | - | 878 Thousand | 807 Thousand |
Common Stock Issuance | 18 Thousand | - | 274.81 Million | 5000.00 | 664 Thousand | 641 Thousand |
Other Financing Activities | -755 Thousand | -463.57 Million | -963.17 Million | -1.8 Million | 1.03 Million | -34 Thousand |
Accounts receivables | -26.14 Million | 45.08 Million | 75.27 Million | 113.67 Million | 83.53 Million | -1.15 Million |
Accounts payables | - | - | - | - | - | 1.42 Million |
Inventory | - | - | - | - | - | 1.14 Billion |
Other working capital | -2.35 Billion | 282.64 Million | -890.07 Million | -691.42 Million | -845.4 Million | -167.14 Million |
Cash at beginning of period | 61.78 Million | 64.89 Million | 69.43 Million | 66.69 Million | 79.7 Million | 51.92 Million |
Cash at end of period | 67.14 Million | 61.78 Million | 64.89 Million | 69.43 Million | 69.43 Million | 66.69 Million |
Capital Expenditure | -10.13 Million | -9.46 Million | -7.66 Million | -11.38 Million | -38.69 Million | -8.52 Million |
Effect of forex changes on cash | 236 Thousand | 2.43 Million | -2.32 Million | 3.75 Million | 1.77 Million | -3.12 Million |
Net cash flow / Change in cash | 5.35 Million | -3.1 Million | -4.54 Million | 2.74 Million | -10.26 Million | 14.76 Million |
Free Cash Flow | -66.72 Million | 1.12 Billion | -788.67 Million | -497.84 Million | -618.87 Million | 883.32 Million |
ITERA
PMT-PC
IAM
PHARM
EACTF
SRS